» Articles » PMID: 36557285

Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids

Overview
Journal Metabolites
Publisher MDPI
Date 2022 Dec 23
PMID 36557285
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiome is a collection of microorganisms and parasites in the gastrointestinal tract. Many factors can affect this community's composition, such as age, sex, diet, medications, and environmental triggers. The relationship between the human host and the gut microbiota is crucial for the organism's survival and development, whereas the disruption of this relationship can lead to various inflammatory diseases. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are used to treat muscle spasticity associated with multiple sclerosis. It is now clear that these compounds also benefit patients with neuroinflammation. CBD and THC are used in the treatment of inflammation. The gut is a significant source of nutrients, including vitamins B and K, which are gut microbiota products. While these vitamins play a crucial role in brain and bone development and function, the influence of gut microbiota on the gut-brain and gut-bone axes extends further and continues to receive increasing scientific scrutiny. The gut microbiota has been demonstrated to be vital for optimal brain functions and stress suppression. Additionally, several studies have revealed the role of gut microbiota in developing and maintaining skeletal integrity and bone mineral density. It can also influence the development and maintenance of bone matrix. The presence of the gut microbiota can influence the actions of specific T regulatory cells, which can lead to the development of bone formation and proliferation. In addition, its metabolites can prevent bone loss. The gut microbiota can help maintain the bone's equilibrium and prevent the development of metabolic diseases, such as osteoporosis. In this review, the dual functions gut microbiota plays in regulating the gut-bone axis and gut-brain axis and the impact of CBD on these roles are discussed.

Citing Articles

Cannabinoids and triple-negative breast cancer treatment.

Dobovisek L, Borstnar S, Debeljak N, Brezar S Front Immunol. 2024; 15:1386548.

PMID: 39176080 PMC: 11338791. DOI: 10.3389/fimmu.2024.1386548.


The Brain-Gut-Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects.

Li R, Miao Z, Liu Y, Chen X, Wang H, Su J Adv Sci (Weinh). 2024; 11(38):e2307971.

PMID: 39120490 PMC: 11481201. DOI: 10.1002/advs.202307971.


Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.

Olteanu G, Ciuca-Pana M, Busnatu S, Lupuliasa D, Neacsu S, Mititelu M Int J Mol Sci. 2024; 25(10).

PMID: 38791599 PMC: 11122276. DOI: 10.3390/ijms25105561.


Microbiota metabolites in bone: Shaping health and Confronting disease.

Han D, Wang W, Gong J, Ma Y, Li Y Heliyon. 2024; 10(7):e28435.

PMID: 38560225 PMC: 10979239. DOI: 10.1016/j.heliyon.2024.e28435.


Shengu granules ameliorate ovariectomy-induced osteoporosis by the gut-bone-immune axis.

Chen X, Li W, Zeng J, Dong Y, Qiu J, Zhang B Front Microbiol. 2024; 15:1320500.

PMID: 38525084 PMC: 10959285. DOI: 10.3389/fmicb.2024.1320500.


References
1.
Huang X, Ma S, Wang L, Zhou H, Jiang Y, Cui W . Lactobacillus johnsonii-activated chicken bone marrow-derived dendritic cells exhibit maturation and increased expression of cytokines and chemokines in vitro. Cytokine. 2020; 136:155269. DOI: 10.1016/j.cyto.2020.155269. View

2.
Kienzl M, Storr M, Schicho R . Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol. 2020; 11(1):e00120. PMC: 7056045. DOI: 10.14309/ctg.0000000000000120. View

3.
Ohlsson C, Nigro G, Gomperts Boneca I, Backhed F, Sansonetti P, Sjogren K . Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling. Cell Immunol. 2017; 317:55-58. DOI: 10.1016/j.cellimm.2017.05.003. View

4.
Cluny N, Keenan C, Reimer R, Le Foll B, Sharkey K . Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol. PLoS One. 2015; 10(12):e0144270. PMC: 4669115. DOI: 10.1371/journal.pone.0144270. View

5.
Bosi A, Banfi D, Bistoletti M, Giaroni C, Baj A . Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease. Int J Tryptophan Res. 2020; 13:1178646920928984. PMC: 7290275. DOI: 10.1177/1178646920928984. View